+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Proteomics: Technologies and Global Markets

  • ID: 4618078
  • Report
  • Region: Global
  • 235 Pages
  • BCC Research
1 of 5

FEATURED COMPANIES

  • Abcodia Ltd.
  • Biomerieux Sa
  • Fluidigm Corp.
  • Merck Kgaa
  • Protagen Ag
  • Sera Prognostics
  • MORE
The Report Scope:

The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOCs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets-North America, Europe, Asia-Pacific, and Rest of the World (ROW)-are included.

The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth through 2022.

Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.

Key industry acquisitions and strategic alliances are given for the three-year period from 2015 through 2018.

This report also examines the main patent trends within the industry and profiles 108 proteomics companies.

The Report Includes:
  • 20 data tables and 62 additional tables
  • An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
  • Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
  • Examination of market trends and opportunities that will impact the future market
  • A look at proteomics scientific initiatives, industry acquisitions and patents
  • Discussion of proteomic applications in drug discovery and development
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
  • Company profiles of major players, including Abcodia Ltd., Bruker Corp., Digilab Inc., Glaxosmithkline Plc., & Luminex Corp
Membership Price:

Contact us for membership pricing.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abcodia Ltd.
  • Biomerieux Sa
  • Fluidigm Corp.
  • Merck Kgaa
  • Protagen Ag
  • Sera Prognostics
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Intended Audience
  • Scope and Format
  • Methodology
  • Information Sources
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Proteomic Technologies
  • Scope of Report
  • Proteomics Market
  • Driving Forces for Proteomics Industry Growth
  • The Proteomics Industry

Chapter 4 Proteomics Technologies

  • Introduction
  • MS-Based Proteomics Technologies
  • Sample Preparation Assays
  • Tagging/Affinity Methods
  • Utility of Proteomics to Identify Biomarkers
  • MS Instruments and Consumables
  • Biochip-Based Proteomics Technologies
  • Multiplex Proteomics Systems
  • Proteogenomics
  • Recent Advances in Proteomics Technologies

Chapter 5 Proteomics Applications in Drug Discovery and Development

  • Target Discovery
  • Lead Identification
  • Lead Optimization
  • Preclinical Studies

Chapter 6 Proteomics Scientific Initiatives

Chapter 7 Clinical Proteomics Applications

  • Applications in Cancer
  • Overview
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Kidney Cancer
  • Lung Cancer
  • Lymphomas
  • Ovarian Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Infectious Diseases
  • Diabetes
  • Neurological Disorders
  • Alzheimer's Disease
  • Schizophrenia
  • Immune Diseases
  • HLA Typing
  • Autoimmune Disease
  • Cardiovascular Disease
  • Preeclampsia

Chapter 8 Proteomics Industry

  • Industry Acquisitions
  • Industry Strategic Alliances
  • Mass Spectrometry Industry
  • Chromatography Industry
  • Proteomics-Based Drug Discovery and Development Industry
  • Proteomics Biochip Industries
  • Peptide Microarray Industry
  • High-Density Protein Array Industry
  • Antibody Microarray Industry
  • China's Biochip Industry
  • LOC Proteomics Industry
  • Chemical Proteomics Industry
  • Antibody Reagent Industry
  • Multiplex Protein Diagnostics Industry
  • Dried Blood Spotting Proteomics Industry
  • Single Cell Proteomics Industry

Chapter 9 Proteomics Markets

  • Driving Forces of Proteomics Industry Growth
  • Global Proteomics Markets
  • Market Summary
  • Research Market
  • Drug Discovery and Development Market
  • Proteomics Diagnostic Market
  • Mass Spectrometry-Based Proteomics Market
  • Biochip-Based Proteomics Market
  • Proteomics Geographic Market

Chapter 10 Proteomics Patents

  • Protein Array Patents
  • Lab-on-a-Chip Patents
  • Mass Spectrometry Patents

Chapter 11 Company Profiles

  • Abcodia Ltd.
  • Ablynx NV (Acquired By Novo Nordisk)
  • Activiomics Ltd.
  • Activx Biosciences Inc.
  • Advanced Proteome Therapeutics Inc.
  • Agilent Technologies Inc.
  • Applied Microarrays
  • Applied Proteomics
  • Arrayit Corp.
  • Astute Medical Inc.
  • Avacta Group Plc.
  • Ayoxxa Biosystems Gmbh
  • Biocartis Nv
  • Biodesix Inc.
  • Biognosys Ag
  • Biomerieux Sa
  • Bioproximity Llc
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Inc.
  • Bruker Corp.
  • Cambridge Protein Arrays Ltd.
  • Caprion Biosciences Inc. (Acquired By Gho Capital)
  • Caprotec Bioanalytics Gmbh (Acquired By Charles River Laboratories International Inc.)
  • Carmenta Bioscience Inc. (Acquired By Progenity Inc.)
  • CDI Laboratories Inc.
  • Crelux Gmbh
  • Crescendo Bioscience (Acquired By Myriad Genetics)
  • Crystalgenomics Inc.
  • Cyvek Inc. (Acquired By Bio-Techne)
  • Danaher Corp.
  • Diassess
  • Digilab Inc.
  • Epicypher Inc.
  • Evotec Ag
  • Fluidigm Corp.
  • General Electric Co.
  • Glaxosmithkline Plc.
  • Global Discovery Biosciences
  • GL Sciences Inc.
  • Healthtell Inc.
  • Hybrigenics Sa
  • Immunovia Ab
  • Imtakt Corp.
  • Integrated Diagnostics
  • Indi Molecular
  • Iris International Inc. (Acquired By Danaher Corp.)
  • Labcyte Inc.
  • Leap Technologies Inc. (Acquired By Trajan Scientific And Medical)
  • Luminex Corp.
  • Merck & Co. Inc.
  • Merck Kgaa
  • Microlytic (Acquired By Anatrace)
  • Mrm Proteomics Inc.
  • Mosaiques Diagnostics And Therapeutics Ag
  • Mycartis
  • Myriad Genetics Inc.
  • Newomics Inc.
  • Nirmidas Biotech Inc.
  • Olink Bioscience
  • Oncoplex Diagnostics (Acquired By Nantomics)
  • Opko Health Inc.
  • Perkinelmer Inc.
  • Personalized Cancer Therapy Inc.
  • Pfizer Inc.
  • Phenomenex Inc.
  • Phylogica Ltd.
  • Pressure Biosciences Inc.
  • Prometic Life Sciences Inc.
  • Protagen Ag
  • Protea Biosciences Inc.
  • Proteocyte Diagnostics Inc.
  • Proteogenix
  • Proteome Sciences Plc.
  • Proteomics International Pty Ltd.
  • Proteovista Llc
  • Provista Diagnostics Inc.
  • Qiagen Nv
  • Quansys Biosciences
  • Quanterix Inc.
  • Quest Diagnostics Inc.
  • Repligen Corp.
  • Retrogenix Ltd.
  • Samdi Tech Inc.
  • Sera Prognostics
  • Shimadzu Corp.
  • Shiseido Company Ltd.
  • Showa Denko Kk
  • Sigma Aldrich (Acquired By Merck)
  • Singulex Inc.
  • Siscapa Assay Technologies Inc.
  • Somalogic Inc.
  • Sphere Fluidics Ltd.
  • Spoton Clinical Diagnostics Ltd.
  • SQI Diagnostics
  • Synageva Biopharma (Acquired By Alexion Pharmaceuticals Inc.)
  • T2 Biosystems
  • Theranostics Health (Acquired By Avant Diagnostics)
  • Thermo Fisher Scientific Inc.
  • Thorne Diagnostics Inc.
  • Tosoh Corp.
  • Universal Biosensors Ltd.
  • Vermillion Inc.
  • VG Life Sciences Inc.
  • Waters Corp.
  • Xencor Inc.
  • YMC Co. Ltd.
  • Zephyrus Biosciences Inc. (Acquired By Bio-Techne Corp.)

List of Tables
Summary Table: Global Proteomics Market, by End-User Industry, Through 2022
Table 1: Global Array versus LOC Biochips
Table 2: Scope of Report
Table 3: Global Proteomics Market by Platform, Through 2022
Table 4: Driving Forces in the Growth of the Proteomics Industry
Table 5: Biochip Industry Comparisons
Table 6: Mass Spectrometry Generalized Workflow Schematic
Table 7: Mass Spectrometer Platforms
Table 8: Biochip-Based Proteomics Technologies
Table 9: Planar-Based Versus Bead-Based Arrays
Table 10: Advantages of Multiplexing for Diagnostics
Table 11: Technical Advances in Proteomics
Table 12: Proteomic Applications in Drug Discovery and Development
Table 13: Large-Scale Proteomics Initiatives
Table 14: Some of the Cancer Markers used in Diagnosis and Treatment
Table 15: Strategies for Overcoming High-Abundance Proteins in Clinical Samples
Table 16: Estimated U.S. Incidence and Deaths for Selected Cancers, 2010, 2013 and 2018
Table 17: Status of Next-Generation Diagnostic Tests for Bladder Cancer
Table 18: Estimated Number of Annual Breast Cancer Treatment Decisions in the U.S., by Cancer Classification
Table 19: Breast Cancer MDx Technology Platforms
Table 20: Status of Next-Generation Diagnostic Tests for Gastric/Stomach Cancer
Table 21: Status of Next-Generation Diagnostic Tests for Kidney Cancer
Table 22: Five-Year Survival Rates for Non-Small Cell Lung Cancer, 2012-2017
Table 23: Status of Next-Generation Diagnostic Tests for Lung Cancer
Table 24: Status of Next-Generation Diagnostic Tests for Lymphomas
Table 25: Early Screening Tests for Ovarian Cancer
Table 26: Status of Next-Generation Diagnostics Tests for Ovarian Cancer
Table 27: Status of Next-Generation Diagnostics Tests for Pan-Cancer
Table 28: Status of Next-Generation Diagnostics Tests for Prostate Cancer
Table 29: Status of Next-Generation Diagnostics Tests for Thyroid Cancer
Table 30: Alzheimer's Disease Diagnostic Approaches
Table 31: Multiplex Autoimmune Testing Market
Table 32: Preeclampsia Diagnostic Tests
Table 33: Proteomics Industry Acquisitions, 2015-2018
Table 34: Strategic Alliances in the Proteomics Industry, 2015 -2018
Table 35: Mass Spectrometry Industry: Porter’s Five Forces Analysis
Table 36: First-Tier Mass Spectrometry Companies
Table 37: Second-Tier Mass Spectrometry Companies
Table 38: Leading Manufacturers of High-Performance Liquid Chromatography Columns
Table 39: Leading Manufacturers of High-Performance Liquid Chromatography Columns in Japan
Table 40: Proteomics-Based Drug Discovery Industry
Table 41: Key Peptide Microarray Companies
Table 42: Leading High-Density Protein Array Companies
Table 43: Key Antibody Microarray Companies
Table 44: Leading Companies in China's Biochip Industry
Table 45: LOC Competitor Landscape
Table 46: Antibody Reagent Market, 2016
Table 47: Multiplex Protein In Vitro Diagnostics Companies
Table 48: Dried Blood Spot Proteomics Industry
Table 49: Single Cell Proteomics Industry
Table 50: Factors driving the growth of the Proteomics Industry
Table 51: Global Proteomic Market, by End-User Industry, Through 2022
Table 52: Global Proteomics Research Market, by Platform, Through 2022
Table 53: Global Proteomics Research Market, by Biochip Platform, Through 2022
Table 54: Global Proteomics Drug Discovery and Development Market, by Platform, Through 2022
Table 55: Global Proteomics Biochip Drug Discovery and Development Market, by Biochip Type, Through 2022
Table 56: Global Proteomics Diagnostic Market, by Platform, Through 2022
Table 57: Global Proteomics Diagnostic Market, by Biochip Type, Through 2022
Table 58: Global Proteomics Diagnostic Market, by Disease Type, Through 2022
Table 59: Status of Proteomics-Based Diagnostics for Diabetes, Neurological, Autoimmune, Infectious Disease, HLA Typing, and Cardiovascular Disease Applications
Table 60: Sepsis Diagnostics Industry
Table 61: Global Proteomics Cancer Diagnostic Market, by Indication, Through 2022
Table 62: Global Mass Spectrometry Market, by Product Type, Through 2022
Table 63: Global Mass Spectrometry Market, by End-User Industry, Through2022
Table 64: MRM-MS versus MALDI MS in Clinical Applications
Table 65: Status of MS Clinical Test Platforms
Table 66: Phosphoproteomics Platforms for Cancer Applications
Table 67: Global Mass Spectrometry Instrument Market for Proteomics, by Technique, Through 2022
Table 68: Global Mass Spectrometry Consumable Market, by Type, Through 2022
Table 69: Global Proteomics Biochip Market, by Platform, Through 2022
Table 70: Global Proteomics Arrays Market, by Type, Through 2022
Table 71: Global Proteomics Biochips Market, by End-User Industry, Through 2022
Table 72: Global Proteomics Array Market, by End-User Industry, Through 2022
Table 73: lobal Proteomics LOC Market, by End-User Industry, Through 2022
Table 74: Global Proteomics Market, by Region, Through 2022
Table 75: Global Proteomic Diagnostic Market, by Region, Through 2022
Table 76: Array-related Proteomics Patents by Region, 2015–2018
Table 77: LOC-related Proteomics Patents by Region, 2015-2018
Table 78: Mass Spectrometry-Related Proteomics Patents, by Region, 2015-2018
Table 79: Applications for Y2H and YChemH Proteomics Platforms
Table 80: Somalogic Proteomics Methods
Table 81: Universal Biosensors Diagnostic Pipeline

List of Figures
Summary Figure: Global Proteomics Market, by End-User Industry, 2016-2022
Figure 1: Proteomics Biochip and Array Formats
Figure 2: Chromatography Proteomics Workflow

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abcodia Ltd.
  • Biomerieux Sa
  • Fluidigm Corp.
  • Merck Kgaa
  • Protagen Ag
  • Sera Prognostics
  • MORE

In May 2014, two independent research groups, one in the U.S. and India, and the other in Germany published the first drafts of the human proteome, which was based on mass spectrometry data. These maps were the most comprehensive to date and signaled the rapid progress in our understanding of the role of genes and their products, proteins.

The draft human proteome signaled the coming of age of proteomics, a field that is rapidly transitioning from research and development application to more applied fields including diagnostics.

The two key proteomics technologies - mass spectrometry and biochips - are benefiting from an explosion of new proteomics content from the large-scale genomic and proteomic initiatives. For instance, according to the Journal of Proteome Research, ACS Publications, the Human Proteome Organization (HUPO) has introduced the Proteomics Standards Initiative (PSI) that is exploring software tools and open community standards in proteomics over the last 15 years (from 2002). Further, HUPO is also credited with completing the protein parts list for the draft human proteome. In addition, HUPO is also exploring the application of proteomics for integration with genomics and transcriptomics across life sciences and biomedical research. This proteomics content is driving the discovery of new biomarkers that are important in disease diagnostic processes such as cancer diagnostics, myocardial infarction, congestive heart failure, and others.

Novel technologies are also driving proteomics applications. For example, increasing miniaturization and integration is occurring in biochip devices and improvements in mass spectrometry workflow and instruments. These innovations are driving proteomics applications in important markets like drug discovery and development and diagnostics. For instance, in 2017, as per the European Association of Urology, the Israeli Institute of Technology developed a silicon biosensor chip that can identify the best antibiotics in just a few hours instead of days and can help in treating a bacterial infection. Furthermore, in 2017, the Georgia Institute of Technology presented that replacing conventional power supplies with Triboelectric Nano-generators (TENG) for charging molecules can boost up the sensitivity of mass spectrometers and can also help in identification of small volumes.

Note: Product cover images may vary from those shown
5 of 5
  • Abcodia Ltd.
  • Ablynx Nv (Acquired By Novo Nordisk)
  • Activiomics Ltd.
  • Activx Biosciences Inc.
  • Advanced Proteome Therapeutics Inc.
  • Agilent Technologies Inc.
  • Applied Microarrays
  • Applied Proteomics
  • Arrayit Corp.
  • Astute Medical Inc.
  • Avacta Group Plc.
  • Ayoxxa Biosystems Gmbh
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Inc.
  • Biocartis Nv
  • Biodesix Inc.
  • Biognosys Ag
  • Biomerieux Sa
  • Bioproximity Llc
  • Bruker Corp.
  • Cambridge Protein Arrays Ltd.
  • Caprion Biosciences Inc. (Acquired By Gho Capital)
  • Caprotec Bioanalytics Gmbh (Acquired By Charles River Laboratories International Inc.)
  • Carmenta Bioscience Inc. (Acquired By Progenity Inc.)
  • CDI Laboratories Inc.
  • Crelux Gmbh
  • Crystalgenomics Inc.
  • Danaher Corp.
  • Diassess
  • Digilab Inc.
  • Epicypher Inc.
  • Evotec Ag
  • Fluidigm Corp.
  • General Electric Co.
  • GL Sciences Inc.
  • Glaxosmithkline Plc.
  • Global Discovery Biosciences
  • Healthtell Inc.
  • Hybrigenics Sa
  • Immunovia Ab
  • Imtakt Corp.
  • Indi Molecular
  • Integrated Diagnostics
  • Iris International Inc. (Acquired By Danaher Corp.)
  • Labcyte Inc.
  • Leap Technologies Inc. (Acquired By Trajan Scientific And Medical)
  • Luminex Corp.
  • Merck & Co. Inc.
  • Merck Kgaa
  • Microlytic (Acquired By Anatrace)
  • Mosaiques Diagnostics And Therapeutics Ag
  • MRM Proteomics Inc.
  • Mycartis
  • Myriad Genetics Inc.
  • Newomics Inc.
  • Nirmidas Biotech Inc.
  • Olink Bioscience
  • Opko Health Inc.
  • Perkinelmer Inc.
  • Personalized Cancer Therapy Inc.
  • Pfizer Inc.
  • Phenomenex Inc.
  • Phylogica Ltd.
  • Pressure Biosciences Inc.
  • Prometic Life Sciences Inc.
  • Protagen Ag
  • Protea Biosciences Inc.
  • Proteocyte Diagnostics Inc.
  • Proteogenix
  • Proteome Sciences Plc.
  • Proteomics International Pty Ltd.
  • Proteovista Llc
  • Provista Diagnostics Inc.
  • Qiagen Nv
  • Quansys Biosciences
  • Quanterix Inc.
  • Quest Diagnostics Inc.
  • Repligen Corp.
  • Retrogenix Ltd.
  • Samdi Tech Inc.
  • Sera Prognostics
  • Shimadzu Corp.
  • Shiseido Company Ltd.
  • Showa Denko Kk
  • Sigma Aldrich (Acquired By Merck)
  • Singulex Inc.
  • Siscapa Assay Technologies Inc.
  • Somalogic Inc.
  • Sphere Fluidics Ltd.
  • Spoton Clinical Diagnostics Ltd.
  • SQI Diagnostics
  • T2 Biosystems
  • Theranostics Health (Acquired By Avant Diagnostics)
  • Thermo Fisher Scientific Inc.
  • Thorne Diagnostics Inc.
  • Tosoh Corp.
  • Universal Biosensors Ltd.
  • Vermillion Inc.
  • VG Life Sciences Inc.
  • Waters Corp.
  • Xencor Inc.
  • YMC Co. Ltd.
  • Zephyrus Biosciences Inc. (Acquired By Bio-Techne Corp.)
Note: Product cover images may vary from those shown
Adroll
adroll